002821.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Stats
Current Price	CNY128.79
Today's Volume	2.73M
Average Volume	4.24M
Market Cap	46.64B
EPS	CNY9.36
P/E	13.76
ATR14	CNY0.0980 (0.08%)

Volume Correlation

Long: -0.94 (very strong negative)

Short: 0.60 (weak)

Signal:(43.548) Neutral

Asymchem Laboratories Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Asymchem Laboratories Correlation - Currency/Commodity

0.71
( moderate )

0.75
( moderate )

0.00
( neutral )

-0.56
( weak negative )

-0.37
( neutral )

0.39
( neutral )

Asymchem Laboratories Financials

Annual 2021
Revenue: CNY4.64B
Gross Profit: CNY2.06B (44.33%)
EPS: CNY4.56

Q3 2022
Revenue: CNY2.77B
Gross Profit: CNY1.30B (46.75%)
EPS: CNY3.75

Q2 2022
Revenue: CNY2.98B
Gross Profit: CNY1.44B (48.25%)
EPS: CNY4.75

Q1 2022
Revenue: CNY2.06B
Gross Profit: CNY932.82M (45.24%)
EPS: CNY1.360

Asymchem Laboratories

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. It has a collaboration agreement with AUM Biosciences to develop and commercialize AUM 601. The company was founded in 1999 and is headquartered in Tianjin, China. AUM Biosciences.